The limits of viability and the uncertainty of neuroprotection: Challenges in optimizing outcomes in extreme prematurity

Pediatrics

Volumn 119, Issue 1, 2007, Pages 158-160

  Msall, Michael E ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

BRAIN HEMORRHAGE; EXTREMELY LOW BIRTH WEIGHT; HIGH RISK PREGNANCY; HUMAN; NEUROPROTECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; NOTE; PERINATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; UNITED STATES; GESTATIONAL AGE; INFANT MORTALITY; NEUROLOGIC DISEASE; NEWBORN;

GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NERVOUS SYSTEM DISEASES;

EID: 33846927073     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3095     Document Type: Note

References (17)

1. March of Dimes. Data Book for Policy Makers: Maternal, Infant and Child Health in the United States. Atlanta, GA: March of Dimes; 2003
2. March of Dimes. PeriStats. Available at: www.marchofdimes.com/peristats. Accessed October 23, 2006
3. Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System: birth data. Available at: www.cdc.gov/nchs/births.htm. Accessed October 23, 2006
4. Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics. 2005;116:635-643
5. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extreme preterm birth. EPICure Study Group. N Engl J Med. 2000;343:378-384
6. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD. Changes in neurodevelopmental outcomes at 18-22 months' corrected age among infants of less than 25 weeks' gestation born in 1993-1999. Pediatrics. 2005;115:1645-1651
7. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966-1972
8. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003;289:1124-1129
9. Tommiska V, Heinonen K, Lehtonen L, et al. No improvement in outcome of nationwide extremely low birth weight infant populations between 1996-1997 and 1999-2000. Pediatrics. 2007;119:29-36
10. Mikkola K, Ritari N, Tommiska V, et al. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997. Pediatrics. 2005;116:1391-1400
11. Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352:9-19
12. Marlow N. Neurocognitive outcome after very preterm birth. Arch Dis Child Fetal Neonatal Ed. 2004;89:F224-F228
13. Bhutta AT, Cleeves MA, Casey PH, et al. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002;288:728-737
14. Murata Y, Itakura A, Matsuzawa K, Okumura A, Wakai K, Mizutani S. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev. 2005;27:17-21
15. Dammann O, Leviton A. Inflammatory brain damage in pre-term newborns: dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004;79:1-15
16. Ment L, Vohr B, Allan W. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics. 2000;105:485-491
17. Msall M, Phelps DL, DiGaudio KM, et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics. 2000;106:998-1005